Oruka Therapeutics to Present at Bank of America Securities 2025 Health Care Conference
Rhea-AI Summary
Oruka Therapeutics (Nasdaq: ORKA), a clinical stage biotech company focused on developing novel biologics for chronic skin diseases including plaque psoriasis, will present at the Bank of America Securities 2025 Health Care Conference.
The presentation is scheduled for Tuesday, May 13th, 2025, at 3:55 PM PT. The company, based in Menlo Park, California, is working to establish new treatment standards in dermatology.
Positive
- Company is developing novel biologics for chronic skin diseases including plaque psoriasis
- Clinical stage status indicates progress in drug development pipeline
- Selected to present at a major healthcare conference, indicating industry recognition
Negative
- None.
News Market Reaction – ORKA
On the day this news was published, ORKA gained 1.65%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
MENLO PARK, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical stage biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases including plaque psoriasis, today announced a presentation at the Bank of America Securities 2025 Health Care Conference on Tuesday, May 13th, 2025, at 3:55 PM PT.
About Oruka Therapeutics
Oruka Therapeutics is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. Oruka’s mission is to offer patients suffering from chronic skin diseases like plaque psoriasis the greatest possible freedom from their condition by achieving high rates of complete disease clearance with dosing as infrequently as once or twice a year. Oruka is advancing a proprietary portfolio of potentially best-in-class antibodies that were engineered by Paragon Therapeutics and target the core mechanisms underlying plaque psoriasis and other dermatologic and inflammatory diseases. For more information, visit www.orukatx.com and follow Oruka on LinkedIn.
Investor Contact:
Alan Lada
(650)-606-7911
alan.lada@orukatx.com
FAQ
When is Oruka Therapeutics (ORKA) presenting at the Bank of America Healthcare Conference 2025?
What diseases does Oruka Therapeutics (ORKA) focus on treating?
Is Oruka Therapeutics (ORKA) a clinical stage biotech company?
Where is Oruka Therapeutics (ORKA) stock listed?
What type of medications is Oruka Therapeutics (ORKA) developing?
